Medicaid generics save low-income patients up to 90% on prescription costs, with average copays of just $6.16 compared to $56.12 for brand-name drugs. Discover how rebates, formularies, and policy drive these savings.
Annual savings from FDA generic drug approvals totaled $445 billion in 2023, with year-to-year fluctuations driven by patent expirations. Learn how generics cut drug costs, who benefits most, and why savings vary annually.
Medications